• Share
  • Email
  • Print

Calvina Bostick

Fax +1.212.536.3901

Calvina Bostick is a partner in the firm’s New York office. Her practice focuses on mergers and acquisitions, private equity investments and other business transactions. She represents public and private companies across a broad range of industries, including healthcare, financial services, technology, media and insurance. She also represents private equity firms, financial institutions and secured lenders.

Ms. Bostick regularly advises clients in the following areas:

  • Domestic and cross-border mergers, stock and asset acquisitions and divestitures
  • Pharmaceutical product acquisitions and licenses
  • Joint ventures and strategic alliances
  • Corporate recapitalizations and reorganizations
  • Private equity and mezzanine financings
  • Secured and unsecured syndicated credit facilities
  • Commercial contracts, including development agreements, manufacturing and supply agreements and license agreements
  • General corporate and commercial matters


  • Legal 500 Next Generation Lawyer, M&A: Middle Market ($500M-$999M), 2018
  • Network Journal Top 40 Under Forty Achievement Award, 2015

Speaking Engagements

  • Delaware Bar Association, “The Ins & Outs of Indemnification Provisions,” November 2009
  • CLE Presentation for a Fortune 500 Company, “M&A and Coordination with Business Lawyers,” June 2011
  • 8th Annual CCWC Career Strategies Conference, “Elements of M&A Transactions,” October 2012
  • 11th Annual CCWC Career Strategies Conference, “Strategies for Surviving a Merger and Acquisition,” September 2015
  • Represented a generic pharmaceutical company in its acquisitions of development and manufacturing companies and contract research organizations in the United States and India.
  • Represented U.S. and U.K.-based pharmaceutical companies in connection with pharmaceutical product acquisitions, development agreements, manufacturing and supply agreements and license agreements.
  • Represented an international stock exchange in connection with its acquisition of a publicly traded U.S. broker-dealer.
  • Represented one of the world’s largest construction companies in its joint venture with a real estate development company to manufacture modular units for the construction of high-rise residential buildings.
  • Represented a global risk advisor, insurance and reinsurance broker in connection with its divestiture of multiple offices.
  • Represented an early-stage pharmaceutical R&D company in connection with a debt financing for the construction of an R&D facility in India.
  • Represented the healthcare division of a Dutch technology company in connection with its acquisition of a U.S. remote cardiac monitoring company.
  • Represented a leading provider of high-technology heating, air-conditioning and refrigeration solutions in a strategic joint venture involving the wholesale distribution of HVAC equipment.
  • Represented a Fortune 100 company in its multi-million dollar acquisition of a global sulfuric acid firm.
  • Represented a specialty metals company in connection with the sale of various groups of its assets in Chapter 11 proceedings.
  • Represented a start-up technology company in private securities offerings.
  • Represented a mezzanine fund in connection with various debt financings of its portfolio companies.
  • Represented a public REIT in connection with its $1 billion unsecured credit facility.